Aim: To examine the time-dependent biomechanical properties of four different implanted synthetic materials. Materials and Methods: 18 New Zealand rabbits were randomly categorized into three groups: group 1 to be evaluated at the 2nd week, group 2 at the 8th week, and group 3 at the 12th week. Before the implantation, baseline values were obtained. Each of the 2 × 5 cm sized materials of mersilene, prolene, ultrapro and vypro mesh were placed in the anterior abdominal fascia. The mesh materials were removed, tensile strength (N/mm2) and ultimate strain (%) were measured by tensinometry and surface area losses (cm2) were calculated. Results: Tensile strength values (mean ± SD) were 9.2 ± 1.5, 8.5 ± 1.2 for mersilene, 25.2 ± 7.3, 14.0 ± 2.9 for prolene, 2.2 ± 0.6, 12.5 ± 1.4 for ultrapro and 8.1 ± 1.6, 7.0 ± 1.8 for vypro at baseline and the 12th week. Ultimate strain values (mean ± SD) were 131.2 ± 46.1, 110.4 ± 98.6 for mersilene, 181.0 ± 26.4, 78.5 ± 14.4 for prolene, 91.5 ± 8.2, 89.6 ± 20.5 for ultrapro and 84.3 ± 8.9, 55.0 ± 13.2 for vypro at baseline and the 12th week. Surface areas (mean ± SD) were 8.87 ± 0.14, 9.38 ± 0.17, 8.4 ± 0.32 and 8.76 ± 0.16 for mersilene, prolene, ultrapro and vypro at the 12th week respectively. Conclusions: Although prolene mesh demonstrated a decrease in its tensile strength it still remains the highest at the 12th week. Considering the significant time-dependent increase in its tensile strength, ultrapro mesh should be studied in humans. A final decision on the preference of ultrapro mesh in sling surgery could be reached after such studies.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.